What was the price for the COO’s Precigen (PGEN) share sale?

The COO’s sale of Precigen (PGEN) Common Stock was executed at a price of $6.86 per share . The transaction involved 32,739 shares and is described as a sale in an open-market or private transaction.

COO sale: Precigen (PGEN) insider trades 32,739 shares via plan

Q: What insider transaction did Precigen (PGEN) report for COO Rutul R Shah?

Precigen (PGEN) reported that COO Rutul R Shah sold 32,739 shares of Common Stock on 2026-08-06 at $6.86 per share in an open-market or private transaction under a Rule 10b5-1 plan .

Q: How many Precigen (PGEN) shares does COO Rutul R Shah hold after the reported sale?

After the reported transaction, COO Rutul R Shah directly holds 465,012 shares of Precigen (PGEN) Common Stock, according to the filing’s post-transaction ownership figure for the non-derivative holding.

Q: Was the Precigen (PGEN) insider transaction made under a Rule 10b5-1 plan?

Yes. The filing notes that the 32,739-share sale was made pursuant to a Rule 10b5-1 plan adopted by the reporting person, and the Rule 10b5-1 checkbox for the filing is also marked as affirmed.

Q: Is the reported Precigen (PGEN) transaction a buy or a sell?

The reported Precigen (PGEN) transaction is a sale . The filing classifies it as a sale in an open-market or private transaction, with 32,739 shares of Common Stock disposed of at $6.86 per share .

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Operating Officer Rutul R Shah completed a sale of 32,739 shares of Common Stock on 2026-08-06 at $6.86 per share in a sale classified as an open-market or private transaction under a Rule 10b5-1 trading plan, and now directly holds 465,012 shares.

Insider Trade Summary 10b5-1

Net Seller: 32,739 shares

Net Sell 1 txn

Insider Shah Rutul R

Role Chief Operating Officer

Sold 32,739 shs ($225K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	32,739	$6.86	$225K

Holdings After Transaction: Common Stock — 465,012 shares (Direct)

Footnotes (1)

F1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person

Key Figures

Shares sold: 32,739 shares Sale price: $6.86 per share Shares held after transaction: 465,012 shares +2 more

5 metrics

Shares sold 32,739 shares Common Stock sold on 2026-08-06 by COO Rutul R Shah

Sale price $6.86 per share Price for the 32,739-share sale of Common Stock

Shares held after transaction 465,012 shares Direct ownership of Common Stock following the sale

Net shares sold 32,739 shares Net sell shares in this Form 4 transaction summary

Transactions classified as sales 1 transaction SellCount reported in transaction summary

Key Terms

Rule 10b5-1 plan, open market or private transaction, Common Stock

3 terms

Rule 10b5-1 plan regulatory

"Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction financial

"Transaction code description: Sale in open market or private transaction"

Common Stock financial

"Security title reported for the transaction is Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:04 PM Accepted by SEC EDGAR 08/07/2026 - 05:04 PM

FAQ

What insider transaction did Precigen (PGEN) report for COO Rutul R Shah?

Precigen (PGEN) reported that COO Rutul R Shah sold 32,739 shares of Common Stock on 2026-08-06 at $6.86 per share in an open-market or private transaction under a Rule 10b5-1 plan.

How many Precigen (PGEN) shares does COO Rutul R Shah hold after the reported sale?

After the reported transaction, COO Rutul R Shah directly holds 465,012 shares of Precigen (PGEN) Common Stock, according to the filing’s post-transaction ownership figure for the non-derivative holding.

Was the Precigen (PGEN) insider transaction made under a Rule 10b5-1 plan?

Yes. The filing notes that the 32,739-share sale was made pursuant to a Rule 10b5-1 plan adopted by the reporting person, and the Rule 10b5-1 checkbox for the filing is also marked as affirmed.

Is the reported Precigen (PGEN) transaction a buy or a sell?

The reported Precigen (PGEN) transaction is a sale. The filing classifies it as a sale in an open-market or private transaction, with 32,739 shares of Common Stock disposed of at $6.86 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Rutul R

(Last)

(First)

(Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN

MARYLAND

20876

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/06/2026		S⁽¹⁾		32,739	D	$6.86	465,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person

	/s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR